mRNA and protein expression of ROCK1, ROCK2 and RhoA are increased in the tissue of breast cancer patients; however, only the increased levels of ROCK1 and RhoA correlate with poor patient prognosis [9–13]. Here, ROCK2 is linked to breast carcinoma.